Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-recombinant human growth hormone in adult growth hormone deficiency (Phase II)
CTR20160363Phase 2Suspended
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- Jul 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of peg-somatropin in adult onset growth hormone deficiency (AGHD), sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Started Jul 2016; status: suspended.
02
Drugs
peg-somatropin
03
Conditions
adult onset growth hormone deficiency (AGHD)
Beyond the preview
Go deeper on CTR20160363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160363.